Abstract

The early diagnosis of Alzheimer’s disease (AD) can allow patients to take preventive measures before irreversible brain damage occurs. It can be seen from cross-sectional imaging studies of AD that the features of the lesion areas in AD patients, as observed by magnetic resonance imaging (MRI), show significant variation, and these features are distributed throughout the image space. Since the convolutional layer of the general convolutional neural network (CNN) cannot satisfactorily extract long-distance correlation in the feature space, a deep residual network (ResNet) model, based on spatial transformer networks (STN) and the non-local attention mechanism, is proposed in this study for the early diagnosis of AD. In this ResNet model, a new Mish activation function is selected in the ResNet-50 backbone to replace the Relu function, STN is introduced between the input layer and the improved ResNet-50 backbone, and a non-local attention mechanism is introduced between the fourth and the fifth stages of the improved ResNet-50 backbone. This ResNet model can extract more information from the layers by deepening the network structure through deep ResNet. The introduced STN can transform the spatial information in MRI images of Alzheimer’s patients into another space and retain the key information. The introduced non-local attention mechanism can find the relationship between the lesion areas and normal areas in the feature space. This model can solve the problem of local information loss in traditional CNN and can extract the long-distance correlation in feature space. The proposed method was validated using the ADNI (Alzheimer’s disease neuroimaging initiative) experimental dataset, and compared with several models. The experimental results show that the classification accuracy of the algorithm proposed in this study can reach 97.1%, the macro precision can reach 95.5%, the macro recall can reach 95.3%, and the macro F1 value can reach 95.4%. The proposed model is more effective than other algorithms.

Highlights

  • Alzheimer’s disease (AD) is a common, irreversible, progressive neurological disease characterized by cognitive impairment, whereby the patient’s memory and thinking ability are slowly damaged over time [1,2]

  • Our key contributions are given below: 1. We propose a new residual network (ResNet) model where a new Mish activation function is selected in the ResNet-50 backbone to replace the Relu function; Sensors 2021, 21, 4182

  • We screened a total of 515 samples, which were divided into 55 AD samples, 255 normal control (NC) samples, and 205 Mild cognitive impairment (MCI) samples

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a common, irreversible, progressive neurological disease characterized by cognitive impairment, whereby the patient’s memory and thinking ability are slowly damaged over time [1,2]. AD is characterized by an insidious onset, slow progression, and irreversible course. Mild cognitive impairment (MCI) is an intermediate state between normal function and AD. It refers to a mild impairment of cognitive and memory functions rather than dementia [5,6]. Accurate diagnosis early in the course of the disease may allow patients to initiate preventive and intervention measures to slow or stop the progression of the disease before irreversible brain damage takes place. The early and accurate diagnosis of AD has important research significance [8,9]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call